Vascular Medicine Conference-CVC 2026

Vascular biomarkers serve as measurable indicators within blood or tissue that shed light on the condition and function of blood vessels. These include markers such as C-reactive protein (CRP), interleukins, adhesion molecules, and lipid-associated factors, all of which are directly connected to phenomena like inflammation, endothelial dysfunction, oxidative stress, and lipid metabolism—core processes implicated in cardiovascular disease.

The clinical value of these biomarkers lies in their ability to flag individuals who may be at elevated risk for atherosclerosis, thrombosis, or other vascular complications, sometimes well before any clinical symptoms emerge. Ongoing monitoring of vascular biomarkers can inform treatment decisions, help evaluate the effectiveness of therapeutic interventions, and offer insights into disease progression.

Integrating biomarker analysis into standard clinical practice supports the early detection of vascular issues, enables more tailored and individualized patient care, and strengthens preventive healthcare strategies aimed at preserving vascular health.